ACHV NASDAQ
Achieve Life Sciences, Inc.
1W: -4.0%
1M: -14.6%
3M: +12.2%
YTD: +45.7%
1Y: +133.6%
3Y: +68.4%
5Y: -22.7%
$7.24
-0.29 (-3.85%)
Weekly Expected Move ±8.4%
$6
$7
$7
$8
$8
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
0.60
Bullish
2 bullish
1 neutral
0 bearish
Articles (7d)
3
Daily Sentiment (7 Days)
Articles (50)
Achieve Life Sciences (NASDAQ:ACHV) Shares Gap Up – Here’s What Happened
Achieve Life Sciences appoints Benjamin Halladay as CFO
Achieve a new Buy at Stifel on potential of smoking cessation drug cytisinicline
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Receives Consensus Rating of “Buy” from Brokerages
Frazier Life Sciences Management L.P. Buys New Stake in Achieve Life Sciences, Inc. $ACHV
Deutsche Bank AG Makes New $506,000 Investment in Achieve Life Sciences, Inc. $ACHV
Achieve Life Sciences (NASDAQ:ACHV) Sets New 12-Month High – Should You Buy?
ACHV: Looking Ahead to Resubmission
HC Wainwright Has Bullish Forecast for ACHV Q3 Earnings
Achieve Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Updates
Achieve Life Sciences (NASDAQ:ACHV) Shares Up 6.5% – Here’s Why
Achieve Life Sciences jumps despite cytisinicline CRL
Achieve Life Sciences Receives Complete Response Letter from FDA for Cytisinicline NDA
ACHV: CEO Enlists New Commercialization Team
Achieve (ACHV) Q1 2026 Earnings Transcript
Earnings Scheduled For May 12, 2026
ACHV: Change of Command Brings Material Funding
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Given Average Rating of “Buy” by Brokerages
12 Health Care Stocks Moving In Thursday's Intraday Session
Achieve Life Sciences Announces Up to $354 Million Private Placement
Achieve Life Sciences Announces Operational Progress Including Completion of Technology Transfer to Adare Pharma Solutions
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Receives Average Rating of “Moderate Buy” from Brokerages
Research Analysts Offer Predictions for ACHV FY2026 Earnings
Zacks Research Has Negative Outlook of ACHV FY2026 Earnings
What is HC Wainwright’s Estimate for ACHV Q1 Earnings?
Achieve Life Sciences Flags FDA Observations While Pushing Launch To 2027 For Smoking Cessation Med
Achieve Life Sciences Sees Unusually Large Options Volume (NASDAQ:ACHV)
ACHV: 2025 Results
Iran is said to offer conditional passage through Strait of Hormuz amid shipping crisis
Achieve Life Sciences outlines first half 2027 cytisinicline launch supported by U.S. manufacturing shift and AI-driven commercialization
12 Health Care Stocks Moving In Tuesday's Intraday Session
Earnings Scheduled For March 24, 2026
Achieve Life Sciences GAAP EPS of -$0.28 misses by $0.01
Achieve Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
Achieve Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
Here are the major earnings before the open Tuesday
Achieve Life Sciences (NASDAQ:ACHV) Share Price Crosses Above 200 Day Moving Average – Time to Sell?
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Receives Consensus Recommendation of “Moderate Buy” from Brokerages
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Given Consensus Rating of “Moderate Buy” by Brokerages
Achieve Life Sciences: A Binary Bet With Cytisinicline And A Potential 2026 Launch
Achieve Life Sciences: Could Be The Best 'Tobacco' Stock For 2026 - Strong Buy
Achieve Life Sciences Announced Granting of New Hire Inducement Awards
Achieve Life Sciences Confirms Promotion of Dr. Mark Rubinstein to Chief Medical Officer
Achieve Life Sciences (NASDAQ:ACHV) Share Price Crosses Above 200-Day Moving Average – Here’s Why
Achieve Life Sciences (NASDAQ:ACHV) Stock Price Passes Above Two Hundred Day Moving Average – Time to Sell?
Achieve Life Sciences to Host Meetings During the J.P. Morgan Healthcare Conference Week
Achieve Life Sciences (NASDAQ:ACHV) Share Price Passes Above Two Hundred Day Moving Average – Here’s What Happened
Achieve Life Sciences Announced Granting of New Hire Inducement Awards
Head-To-Head Survey: Achieve Life Sciences (NASDAQ:ACHV) vs. Carisma Therapeutics (NASDAQ:CARM)
Achieve Life Sciences (NASDAQ:ACHV) Stock Price Crosses Above 200-Day Moving Average – Here’s Why